Early diagnosis and therapy of Parkinson’s disease: can disease progression be curbed?
Published 2012 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Early diagnosis and therapy of Parkinson’s disease: can disease progression be curbed?
Authors
Keywords
Parkinson’s disease, Biomarker, Disease-modifying drugs, Neuroimaging, Clinical trial design, Alpha-synuclein, LRRK2, Parkin, PINK1, DJ1
Journal
JOURNAL OF NEURAL TRANSMISSION
Volume 120, Issue 1, Pages 197-210
Publisher
Springer Nature
Online
2012-06-26
DOI
10.1007/s00702-012-0840-9
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Parkinson's Disease: Gene Therapies
- (2013) P. G. Coune et al. Cold Spring Harbor Perspectives in Medicine
- Monoamine Oxidase Inhibitors as Neuroprotective Agents in Age-Dependent Neurodegenerative Disorders
- (2012) Makoto Naoi et al. CURRENT PHARMACEUTICAL DESIGN
- Iron dysregulation in movement disorders
- (2012) Petr Dusek et al. NEUROBIOLOGY OF DISEASE
- Pedunculopontine nucleus deep brain stimulation in Parkinson’s disease
- (2011) Tomasz Tykocki et al. Archives of Medical Science
- Preclinical Biomarkers of Parkinson Disease
- (2011) Yuncheng Wu et al. ARCHIVES OF NEUROLOGY
- Treatment of depressive symptoms in Parkinson’s disease
- (2011) P. Barone EUROPEAN JOURNAL OF NEUROLOGY
- Pitx3 Is a Critical Mediator of GDNF-Induced BDNF Expression in Nigrostriatal Dopaminergic Neurons
- (2011) C. Peng et al. JOURNAL OF NEUROSCIENCE
- Interpreting the results of Parkinson's disease clinical trials: Time for a change
- (2011) Nick H. G. Holford et al. MOVEMENT DISORDERS
- Rate of 6-[18F]fluorodopa uptake decline in striatal subregions in Parkinson's disease
- (2011) Catherine L. Gallagher et al. MOVEMENT DISORDERS
- The impact of non-motor symptoms on health-related quality of life of patients with Parkinson's disease
- (2011) Pablo Martinez-Martin et al. MOVEMENT DISORDERS
- A critical appraisal of the premotor symptoms of Parkinson's disease: Potential usefulness in early diagnosis and design of neuroprotective trials
- (2011) Anthony E. Lang MOVEMENT DISORDERS
- Priorities in Parkinson's disease research
- (2011) Wassilios G. Meissner et al. NATURE REVIEWS DRUG DISCOVERY
- Das präsymptomatische Stadium neurodegenerativer Erkrankungen
- (2011) C. Klein et al. NERVENARZT
- Properly scaled and targeted AAV2-NRTN (neurturin) to the substantia nigra is safe, effective and causes no weight loss: Support for nigral targeting in Parkinson's disease
- (2011) Raymond T. Bartus et al. NEUROBIOLOGY OF DISEASE
- Novel molecular targets of the neuroprotective/neurorescue multimodal iron chelating drug M30 in the mouse brain
- (2011) L. Kupershmidt et al. NEUROSCIENCE
- Deep brain stimulation of globus pallidus interna, subthalamic nucleus, and pedunculopontine nucleus for Parkinson's disease: Which target?
- (2011) Kenneth A. Follett et al. PARKINSONISM & RELATED DISORDERS
- Vaccination for Parkinson's disease
- (2011) A. Schneeberger et al. PARKINSONISM & RELATED DISORDERS
- Dopaminergic Neuronal Loss, Reduced Neurite Complexity and Autophagic Abnormalities in Transgenic Mice Expressing G2019S Mutant LRRK2
- (2011) David Ramonet et al. PLoS One
- α-Synuclein Reactive Antibodies as Diagnostic Biomarkers in Blood Sera of Parkinson's Disease Patients
- (2011) Kiran Yanamandra et al. PLoS One
- Passive Immunization Reduces Behavioral and Neuropathological Deficits in an Alpha-Synuclein Transgenic Model of Lewy Body Disease
- (2011) Eliezer Masliah et al. PLoS One
- Microglial glucocorticoid receptors play a pivotal role in regulating dopaminergic neurodegeneration in parkinsonism
- (2011) F. Ros-Bernal et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- MAO-inhibitors in Parkinson's Disease
- (2011) Peter Riederer et al. Experimental Neurobiology
- Age-specific progression of nigrostriatal dysfunction in Parkinson's disease
- (2010) Raúl de la Fuente-Fernández et al. ANNALS OF NEUROLOGY
- Survivin: A target from brain cancer to neurodegenerative disease
- (2010) Sara Baratchi et al. CRITICAL REVIEWS IN BIOCHEMISTRY AND MOLECULAR BIOLOGY
- Loss of the Parkinson's disease-linked gene DJ-1 perturbs mitochondrial dynamics
- (2010) I. Irrcher et al. HUMAN MOLECULAR GENETICS
- The Endoplasmic Reticulum Stress Sensor, ATF6α, Protects against Neurotoxin-induced Dopaminergic Neuronal Death
- (2010) Naohiro Egawa et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- The Anti-Parkinsonian Drug Selegiline Delays the Nucleation Phase of α-Synuclein Aggregation Leading to the Formation of Nontoxic Species
- (2010) Carolina A. Braga et al. JOURNAL OF MOLECULAR BIOLOGY
- The relevance of iron in the pathogenesis of Parkinson’s disease
- (2010) Jeswinder Sian-Hülsmann et al. JOURNAL OF NEUROCHEMISTRY
- LRRK2 G2019S Mutation Induces Dendrite Degeneration through Mislocalization and Phosphorylation of Tau by Recruiting Autoactivated GSK3
- (2010) C.-H. Lin et al. JOURNAL OF NEUROSCIENCE
- A QUICK Screen for Lrrk2 Interaction Partners – Leucine-rich Repeat Kinase 2 is Involved in Actin Cytoskeleton Dynamics
- (2010) Andrea Meixner et al. MOLECULAR & CELLULAR PROTEOMICS
- A double-blind, placebo-controlled study to assess the mitochondria-targeted antioxidant MitoQ as a disease-modifying therapy in Parkinson's disease
- (2010) Barry J. Snow et al. MOVEMENT DISORDERS
- Bioactivity of AAV2-neurturin gene therapy (CERE-120): Differences between Parkinson's disease and nonhuman primate brains
- (2010) Raymond T. Bartus et al. MOVEMENT DISORDERS
- Clinical trials of disease-modifying therapies for neurodegenerative diseases: the challenges and the future
- (2010) Anthony E Lang NATURE MEDICINE
- Practice Parameter: Treatment of nonmotor symptoms of Parkinson disease: Report of the Quality Standards Subcommittee of the American Academy of Neurology
- (2010) T. A. Zesiewicz et al. NEUROLOGY
- Loss of leucine-rich repeat kinase 2 causes impairment of protein degradation pathways, accumulation of -synuclein, and apoptotic cell death in aged mice
- (2010) Y. Tong et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Rasagiline: A novel anti-Parkinsonian monoamine oxidase-B inhibitor with neuroprotective activity
- (2010) Orly Weinreb et al. PROGRESS IN NEUROBIOLOGY
- Efficient Generation of Functional Dopaminergic Neurons from Human Induced Pluripotent Stem Cells Under Defined Conditions
- (2010) Andrzej Swistowski et al. STEM CELLS
- A critical evaluation of the ubiquitin–proteasome system in Parkinson's disease
- (2009) Casey Cook et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE
- Anti-melanin antibodies are increased in sera in Parkinson's disease
- (2009) K.L. Double et al. EXPERIMENTAL NEUROLOGY
- The neuroprotective mechanism of 1-(R)-aminoindan, the major metabolite of the anti-parkinsonian drug rasagiline
- (2009) Orit Bar-Am et al. JOURNAL OF NEUROCHEMISTRY
- Chronic dopaminergic stimulation in Parkinson's disease: from dyskinesias to impulse control disorders
- (2009) Valerie Voon et al. LANCET NEUROLOGY
- Neuroprotection trials in Parkinson's disease: Systematic review
- (2009) Robert G. Hart et al. MOVEMENT DISORDERS
- Genome-wide association study identifies common variants at four loci as genetic risk factors for Parkinson's disease
- (2009) Wataru Satake et al. NATURE GENETICS
- Transcription factor PITX3 gene in Parkinson's disease
- (2009) Weidong Le et al. NEUROBIOLOGY OF AGING
- Genetic iron chelation protects against proteasome inhibition-induced dopamine neuron degeneration
- (2009) Wen Zhu et al. NEUROBIOLOGY OF DISEASE
- Leucine-Rich Repeat Kinase 2 Regulates the Progression of Neuropathology Induced by Parkinson's-Disease-Related Mutant α-synuclein
- (2009) Xian Lin et al. NEURON
- BDNF mediates the neuroprotective effects of positive AMPA receptor modulators against MPP+-induced toxicity in cultured hippocampal and mesencephalic slices
- (2009) H. Jourdi et al. NEUROPHARMACOLOGY
- Restoration of Nigrostriatal Dopamine Neurons in Post-MPTP Treatment by the Novel Multifunctional Brain-Permeable Iron Chelator-Monoamine Oxidase Inhibitor Drug, M30
- (2009) Shunit Gal et al. NEUROTOXICITY RESEARCH
- A Double-Blind, Delayed-Start Trial of Rasagiline in Parkinson's Disease
- (2009) C. Warren Olanow et al. NEW ENGLAND JOURNAL OF MEDICINE
- Multipoint analysis of reduced 125I-meta-iodobenzylguanidine uptake and norepinephrine turnover in the hearts of mice with 1-methyl-4-phenyl-1,2,3,6-tetrahydroxypyridine-induced parkinsonism
- (2009) Nobuyoshi Fukumitsu et al. NUCLEAR MEDICINE AND BIOLOGY
- Prevalence of smell loss in Parkinson's disease – A multicenter study
- (2009) A. Haehner et al. PARKINSONISM & RELATED DISORDERS
- Repression of -synuclein expression and toxicity by microRNA-7
- (2009) E. Junn et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Imaging neurodegeneration in Parkinson's disease
- (2008) Nicola Pavese et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE
- Emerging pathways in genetic Parkinson’s disease: Autosomal-recessive genes in Parkinson’s disease - a common pathway?
- (2008) Julia C. Fitzgerald et al. FEBS Journal
- Comparison of neuroprotective and neurorestorative capabilities of rasagiline and selegiline against lactacystin-induced nigrostriatal dopaminergic degeneration
- (2008) Wen Zhu et al. JOURNAL OF NEUROCHEMISTRY
- Decreased NURR1 gene expression in patients with Parkinson's disease
- (2008) Weidong Le et al. JOURNAL OF THE NEUROLOGICAL SCIENCES
- Neuropsychological and psychiatric changes after deep brain stimulation for Parkinson's disease: a randomised, multicentre study
- (2008) Karsten Witt et al. LANCET NEUROLOGY
- A voxel-based PET study of dopamine transporters in Parkinson's disease: Relevance of age at onset
- (2008) Andrea Panzacchi et al. NEUROBIOLOGY OF DISEASE
- Invited Article: Nervous system pathology in sporadic Parkinson disease
- (2008) H. Braak et al. NEUROLOGY
- Midbrain iron content in early Parkinson disease: A potential biomarker of disease status
- (2008) W. R. W. Martin et al. NEUROLOGY
- Cardiac MIBG scintigraphy in Primary Progressive Freezing Gait
- (2008) Maria Salsone et al. PARKINSONISM & RELATED DISORDERS
- Loss of PINK1 causes mitochondrial functional defects and increased sensitivity to oxidative stress
- (2008) C. A. Gautier et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- MPTP-induced deficits in striatal synaptic plasticity are prevented by glial cell line-derived neurotrophic factor expressed via an adeno-associated viral vector
- (2007) Yuan-Hao Chen et al. FASEB JOURNAL
- α-Synuclein activates stress signaling protein kinases in THP-1 cells and microglia
- (2006) Andis Klegeris et al. NEUROBIOLOGY OF AGING
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started